FoxWayne Enterprises Acquisition Corp.
FOXW
NASDAQ Capital Market10.25
USD
+0.05
- -
CIK
0001829999
ISIN
US35166L1098
CUSIP
35166L109
Return %
Stock
S&P500
1Y
2.50
18.21
3Y
2.09
64.38
5Y
2.09
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Robb Knie
- Sector
- Financial Services
- Industry
- Shell Companies
- Address
- 1 Rockefeller Plaza New York City NY United States of America 10020
- IPO Date
- Feb 25, 2021
- CIK
- 0001829999
- Website
- foxwayne.com
- Similar Companies
- Business
- FoxWayne Enterprises Acquisition Corp. (FOXW) operates as a blank check company whose principal activity centers on pursuing an initial business combination through merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar transaction with one or more businesses. The company maintains no current operating products or services and generates no revenue, as it functions solely as a special purpose acquisition vehicle seeking a suitable target. Incorporated in 2020 and headquartered in New York, New York, FoxWayne targets opportunities primarily in the biotechnology and/or telemedicine sectors of the healthcare industry or the broader technology industry, with a focus on North America. In December 2021, FoxWayne announced a definitive business combination agreement with Aerami Therapeutics, an inhaled drug delivery developer, under which it planned to issue 25 million shares valued at approximately $250 million to create Aerami Therapeutics Holdings, Inc., listed on Nasdaq; the transaction, initially targeted for early 2022, received extensions including one to April 2022 but ultimately terminated. Subsequently, in January 2023, FoxWayne redeemed all public shares and canceled them effective January 27, 2023, after failing to consummate any initial business combination, marking the wind-down of its SPAC operations with no further mergers or acquisitions reported.